SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY)

KACTUS

SARS-COV-2 Spike S1 (N501Y) Protein (COV-VM1SY)

9

Research Use Only

>95%

A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat.It is characterised by multiple mutations in the spike protein. Among them, N501Y is of major concern because it involves one of the six key amino acid residues determining a tight interaction of the SARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme 2 (ACE2).

-20°C or -80°C,-80°C

12352202